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1013-146 Enhanced Levels of CD154 on Platelets in Patients With 
Congestive Heart Failure 
vStumDf, Christoph Lehner, Susanne Ropers, Saeed Eskafi, Alexander 
Schmeisser, Werner 0. Daniel, Chrfstoph D. Garlichs. Medical Clinic II - University of 
Erlangen/ Nuremberg, Eriangen, Germany 
The purpose of the present study was to examine the role of CD154 on platelets in patients 
with various degrees of congestive heat-l failure (CHF). 
CD154 plays a key role in the patftophysiology of multicellular vascular events such as 
thrombosis, inflammation and atherosclerosis. On the other hand inflammation plays a sig 
nificant contributory role in the pathcgenesis of CHF. Previous data showed enhanced 
plasma levels of proinflammatory cytokines. i.e. TNF-alpha and interleukin 6 as well as per- 
sistent immune activation in patients with CHF. Since CD154 on activated platelets initiates 
and maintains the release of proinflammatory cytokines from endothelial cells, its potential 
role for the development and progression of CHF is of great interest. 
We analyzed the surface levels of CD154 on platelets in 33 patients with CHF of NYHA 
functional class II-IV (67.7k11.2 years, mean ejection fraction 20.9%. 17 of ischemic origin. 
16 with idiopathic dilated cardiomyopathy) and 15 healthy controls (C, 62.5 f 9.6 years). 13 
patients ware aspirin free and 20 patients were taking aspirin (100 mgl day). Blood sam- 
ples were drawn from a peripheral vein and immediately fixed with 1% paraformaldehyde. 
Another sample was centrifuged for preparation of platelet&h plasma (PRP). Samples 
were thereafter stained with anti-CD154, anti-P-selectin and anti-CD61 (for identification of 
platelets), platelets were analyzed by flow cytometry. 
CHF patients showed significantly enhanced expression of platelet-bound CD164 and P- 
selectin as compared to healthy controls (CD154: 37.731t14.66 vs 9.35i5.65 mean fluores- 
cence intensity [MFI], p<O.OOl; Pselectin: 5.19k1.79 vs 1.25kO.59 MFI, pcO.001). CD154 
expression on platelets positively correlated with increase in NYHA-class. There was no 
significant correlation between CD154 and P-selectin expression neither in controls nor in 
patients. Aspirin therapy did not influence the CD154 or P-selectin expression. 
This first demonstration of enhanced levels of surface CD154 in patients with CHF sug 
gests that the CD40CD154 axis may contribute to the proinflammatory milieu existing in 
CHF and thus may play a pathogenic role in the development and progression of CHF. 
1013-147 Enhanced Monocyte Tissue Factor Procoagulant 
Activity in Heart Failure Is Associated With Apoptosis 
m, Mark A. Munger, Christi M. Terry Surakit Natisuwan, James S. Zebrack, 
Edward M. Gilbert, Karleen S. Callahan, University of Utah, .%-If Lake CirV. Utah. 
BACKGROUND: Tissue factor (TF) is a glycoprotein essential in the initiation of coagula- 
tion, and its elevation is linked to thrombotic events. We previously observed a 3.fold ale- 
vation in monocyte TF procoagulant activity (TF-PCA) in heart failure patients compared 
to age-matched controls. Patients with TF-PCA above the median also suffered from 
increased heart failure morbidity and mortality (R&1.15, p=O.O04). However, the mecha- 
nisms for increased TF-PCA in heart failure are not clear. We hypothesize that elevated 
monocyte TF-PCA in heart failure is associated with monocyte apoptosis. 
METHODS: Sixteen NYHA functional class II-IV heart failure patients and 11 diseasa- 
free individuals were studied. Monccytes were isolated from 45 mL of blood collected 
from each subject. Monocyte TF-PCA was determined by a recalcification assay. Cell 
surface TF was measured by a TF-specific antibody via flow cytometry. lnternucleosomal 
DNA cleavage, a hallmark of apoptosis, was quantified by an immunoassay. Presence of 
phosphatidylserine, a phospholipid redistributed to the cell surface during apoptosis, was 
quantified by flow cytometry using Annexin V antibodies with exclusion of non-viable 
cells. 
RESULTS: Total TF-PCA (normalized to protein) was higher in heart failure patients 
(59.26 mU/mcg) than in controls (37.55 mU/mcg), p=O.O46. Cell surface TF levels were 
minimally higher in head failure patients (TF positive cells 5.4% vs 3.6%; median fluores- 
cence 1.16 vs 1.11, p=O.O06). Monocyte DNA cleavage (apoptosis) was increased in 
heart failure subjects compared to controls (69.4 mU vs 40.6 mU of nucleosomes, 
p=O.O09). Annexin V markers of apoptosis ware also correspondingly elevated in head 
failure. 
CONCLUSIONS: Although monocyte TF-PCA is significantly enhanced in heart failure, 
cell surface TF levels are only minimally elevated. The enhanced monocyte TF-PCA is 
also associated with monocyte apoptosis. As apoptosis increases cell surtace phosphati- 
dylserine which enhances TF function without changing TF levels. monocyte apoptosis 
possibly plays a role in increased TF-PCA in heart failure. Further study of monocyte 
apoptosis’ clinical relevance in heart failure is warranted. 
1013-146 Transgenic Overexpression of Neuropeptide Y (NPY) in 
Rats: A Novel Cardiomyopathy Model 
m, Hong Kan, Abnash C. Jain, Mitchell S. Finkel, West Virginia 
University, Morganfown, West Virginia. 
Elevated plasma levels of neuropeptida Y (NPY) have been observed in various clinical 
conditions (congestive heart failure, myocardial infarction and ischemia). but its patho- 
physiologic significance is unknown. Results of shod term experiments have shown both 
positive and negative inotropic effects of NPY on cardiac myccytes, depending on which 
NPY subtype receptors are activated. Acute systemic administration of NPY has been 
reported to decrease myocardial contractility in rats. A transganic rat model with ovar- 
JACC March 6,2002 
expression of NPY (NPY-T) has been developed in Sprague-Dawley rats. Echccardio- 
graphic assessment of cardiac morphology and function was performed in 6 NPY-T rats 
and 6 litter mate controls (NPY-C) under isoflurane anesthesia utilizing a HP 4500 Sonos 
and a 12 MHz transducer, with sonographer and interpreting physician blinded to rat 
identity. NPY-T rats had lower percentage of fractional shortening (%FS) than NPY-C 
(39.4%+4.5% vs. 47.1%*5.9%, PcO.05, N=6) and larger left ventricular internal dimen- 
sions in diastole (LVIDd 6.76*0.17mm vs. 7.66+0.57mm, P<O.O1, N=6) and in systole 
(LVIDs 5.24t0.32 mm vs. 4.15+0.65mm. P<O.Ol, N=6). Mitral inflow velocities were 
obtained in all rats, but fusion of E and A velocities in NPY-C (perhaps due to higher 
heart rate) did not allow for direct comparison with NPY-T. However, the ratio of systolic 
to diastolic flow velocities during pulmonary venous sampling (PV S/D) was significantly 
higher in NPY-T than in NPY-C (0.75+0.14 vs. 0.56+0.10, PsO.05, N=6. Mitral regurgita- 
tion (MR) by color flow and/or spectral Doppler was detected in 2 of 6 NPY-T but in no 
NPY-C. Our echocardiographic data indicates than NPY-T rats demonstrate characteris- 
tics of human dilated cardiomyopathies: dilated LV with reduced %FS, alterations in dias- 
tolic function, and MR. NPY-T may serve as a novel model for human cardiomyopathy. 
1013-149 Seiegiline Attenuates Myocyte Apoptosis by Modulation 
of Bci-2 and Bax in Heart Failure: Association With 
Improvement of Cardlac Function 
&&Q&IQ&, Jeffrey D. Joss, Junya Shite, Chang-sang Liang, University of Rochester 
Medical Center, Rochester, New York. 
Background: We have shown previously that selegiline exerts a cardiac neuroprotective 
effect in chronic hear-l failure (CHF). Since selegiline also has been demonstrated to 
have an antioxidant antiapoptotic effect, we proposed in this study to determine whether 
selegiline attenuates myocyte apoptosis in CHF by modulating 6~1-2 and Bax protein 
expression and whether the effects are associated with improvement of cardiac function. 
Methods: Selegiline (1 mg/day, 6 weeks) was administered to rabbits with pacing- 
induced CHF and sham-operated animals without pacing (Sham). We measured cardiac 
function by echocardiography, myocyte apoptosis by monoclonal antibody to single 
stranded DNA (apoptotic nuclei per 10,000 myocytes), and Bcl-2 and Bax protein ewpres- 
sion by Western blot (arbitrary units) and immunohistochemistry. Results: Rapid pacing 
produced clinical heart failure, cardiac dilation and decrease in left ventricular (LV) frac- 
tional shortening (FS). These changes were associated with increased myocyte apopto- 
sis, decreased B&2 protein, increased Bax protein, and decreased Bcl-2 to Bax ratio. 
Selegiline prevented the changes of 8~1-2 and Bax and greatly attenuated myocyte apo- 
ptosis. It also improved LV FS slightly. Conclusion: The reduction of myocyte apoptosis 
by selegillne in CHF involves alterations in Bcl-2 and Bax protein expression. The effects 
are potentially beneficial in improvement of cardiac function in CHF. 
Group Apoptotic nuclei Bcl-2 protein Bax protein Bcl-2/Bax LV FS% 
Sham 15.7k3.9 1 .oOztO.o9 1.05M.06 l.OM0.10 34.6fi.9 
Sham+selegiline 15.1i2.5 1.07rn.06 1.04+0.03 1.03*0.05 32.6ztOo.6 
CHF 77.2k14.1’ 0.6OztO.03’ 1.26fl.05’ 0.66M.03’ 16.3fl.O’ 
CHFcselegiline 26.9f3.5’t 0.93+0.04T 1.04m.07T 0.94m.osT 21.910.4*t 
N=6. Values are meanf.SE. ‘PcO.05 vs Sham. tPc0.05 vs CHF 
1013-150 Evaluation of Diastolic Dysfunction Using a 
Recirculation Fraction Model of Sarcoplasmic 
Reticulum Function 
D. Curtis Deno, &&b&&&f, Lawrence J. Mulligan, Medtronic Cardiac Rhythm 
Management, Minneapolis, Minnesota. 
Background: Heart failure is associated with diastolic dysfunction due to defects in cal- 
cium cycling in the sarcoplasmic reticulum (SR). Recirculation fraction (RF) is obtained 
from several cardiac cycles as a transient excess of calcium from force-interval manipu- 
lations is dissipated. We compared RF with other diastolic parameters in viva under vari- 
ous levels of contractile function. 
Methods: The cardiac function of 6 anesthetized dogs was manipulated acutely by 
inhaled isoflurane (3%). calcium chloride infusion (100 mglmin), and high rate pacing 
(HRP, > 260 bpm for 2-5 minutes). RF was calculated from the decay of LV dP/dt,,,,, fol- 
lowing paced or intrinsic extrasystoles according to x = x, + (RF)k x Ax for cardiac cycle k 
2 0. Conditions were compared with baseline and each other using a linear mixed model 
adjusting for multiple comparisons. 
Results: Significant differences from baseline (p < 0.05) are indicated in the table (‘). 
Changes in RF paralleled those seen with dP/dt but not relaxation time constant (tau) or 
end diastolic pressure (EDP). Despite comparable reductions of RF under isoflurane and 
HRP, tau and EDP were increased with HRP only. 
Concfusfons: RF may provide information about diastolic function complementary to tau 
and EDP. The threefold prolongation of tau under HRP may arise from an HRP specific 
impairment of Ca** reuptake. This is consistent with prior explanations of isoflurane dys- 
function caused by diminished Caa’ release and HRP dysfunction associated with 
impaired SR Ca*+ reuptake. 
Baseline lsoflurane Calcium HighRate 
LV RF 0.64350.067 0.372iO.280’ 0.906+0.067’ 0.203+0.134’ 
LV +dP/dt (mmHg/s) 1367e.262 603t194’ 2696+515’ 509*231* 
LV Tau (ms) 34.9t6.6 34.9*1.9 24.023.6 103.5i16.0 
LV EDP (mmHg) 6.1~2.9 5.2k3.5 4.6k1.9 10.9t6.2 
